Close

Aquestive Therapeutics (AQST) Confirms Licensee Sunovion Pharmaceuticals' Received CRL for Apomorphine Sublingual Film (APL-130277) NDA

January 31, 2019 8:59 AM EST Send to a Friend
Aquestive Therapeutics, Inc. (NASDAQ: AQST), a specialty pharmaceutical company focused on developing and commercializing differentiated products to solve therapeutic problems ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login